跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DASATINIB ACCORD HEALTHCARE 140 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DASATINIB ACCORD HEALTHCARE 140 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
DASATINIB ACCORD HEALTHCARE 140 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Accord Healthcare S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 4, 2024
Approval ID
578ad3d4227cef5c
Company
Accord Healthcare S.L.U.
Type
Standard
Approval Details
Approval Id
578ad3d4227cef5c
Drug Cima Aemps Name
DASATINIB ACCORD HEALTHCARE 140 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
1241839021
Holder Company Name
Accord Healthcare S.L.U.
Marketing Company Name
Accord Healthcare S.L.U.
Holder Company Detail Path
/organization/accord-healthcare-sl
Marketing Company Detail Path
/organization/accord-healthcare-sl
Authorization Date
2024-10-04
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
140 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Accord Healthcare S.L.U.
Company Detail Path
/organization/accord-healthcare-sl
Company Information
Pharmaceutical Company Name
ACCORD HEALTHCARE SL
Country Name
Spain
City Name
barcelona,barcelona,country_es
Address
CALLE MOLL BARCELONA (WORLD TRADE CENTER EDIF. ESTE), S/N
Active Ingredients
DASATINIB MONOHIDRATO
145,17 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 4, 2024
Approval ID
578ad3d4227cef5c
Type
Standard
Back to CIMA-AEMPS Approvals